- Home
- WASH vs VIR Comparison
WASH vs VIR Comparison
Compare WASH & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- VIR
- Stock Information
- Founded
- WASH 1800
- VIR 2016
- Country
- WASH United States
- VIR United States
- Employees
- WASH N/A
- VIR N/A
- Industry
- WASH Major Banks
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- VIR Health Care
- Exchange
- WASH Nasdaq
- VIR Nasdaq
- Market Cap
- WASH 647.4M
- VIR 844.9M
- IPO Year
- WASH N/A
- VIR 2019
- Fundamental
- Price
- WASH $28.38
- VIR $5.09
- Analyst Decision
- WASH Buy
- VIR Strong Buy
- Analyst Count
- WASH 3
- VIR 7
- Target Price
- WASH $33.67
- VIR $33.57
- AVG Volume (30 Days)
- WASH 162.5K
- VIR 1.0M
- Earning Date
- WASH 04-21-2025
- VIR 05-07-2025
- Dividend Yield
- WASH 7.89%
- VIR N/A
- EPS Growth
- WASH N/A
- VIR N/A
- EPS
- WASH N/A
- VIR N/A
- Revenue
- WASH $110,088,000.00
- VIR $20,861,000.00
- Revenue This Year
- WASH $59.25
- VIR N/A
- Revenue Next Year
- WASH $9.15
- VIR $10.65
- P/E Ratio
- WASH N/A
- VIR N/A
- Revenue Growth
- WASH N/A
- VIR N/A
- 52 Week Low
- WASH $24.70
- VIR $4.95
- 52 Week High
- WASH $40.59
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- WASH 51.42
- VIR 31.53
- Support Level
- WASH $27.68
- VIR $5.04
- Resistance Level
- WASH $28.74
- VIR $6.29
- Average True Range (ATR)
- WASH 0.66
- VIR 0.30
- MACD
- WASH 0.22
- VIR -0.02
- Stochastic Oscillator
- WASH 85.83
- VIR 3.57
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.